Jennifer McMahon
Directeur/Membre du Conseil chez Biosensia Ltd.
Profil
Jennifer McMahon is a Partner at Seroba.
She graduated from UCD with an honours degree in Pharmacology in 2010.
Jennifer then entered a Master’s degree programme in Biotechnology and Business to further her interest in the interface of biomedical science with commercialisation.
Having placed first in her Master’s degree in 2011, Jennifer then joined Seroba’s Investment Team as an Investment Analyst, progressing to Partner in 2022.
In 2019, Jennifer joined the Advisory Board for the European healthcare Businesswomen’s Association.
She is Chair of Level20 Europe and was a founder member of the Ireland Chapter of Level20.
She guest lectures on venture capital at University College Dublin, Trinity College Dublin and the Royal College of Surgeons in Ireland.
She is also in high demand as a speaker at Investor/Entrepreneur life science partnering conferences across Europe.
Jennifer sits on the boards of Endotronix and Palliare, is a Board Observer to Shorla Pharma and was previously on the Board of Biosensia prior to its merger with Kypha Diagnostics.
Postes actifs de Jennifer McMahon
| Sociétés | Poste | Début |
|---|---|---|
Seroba BioVentures Ltd.
 Seroba BioVentures Ltd. Investment ManagersFinance Seroba BioVentures Ltd (Seroba BioVentures) is a venture capital subsidiary of Kernel Management Partners Ltd founded in 2001 by Peter Sandys and Seamus O''Hara. The firm is headquartered in Dublin, Ireland. | Analyste en capital-investissement | 01/01/2011 |
Endotronix, Inc.
 Endotronix, Inc. Medical SpecialtiesHealth Technology Endotronix, Inc. develops wireless heart sensor technology. The firm has introduced the Cordella Heart Failure System, a comprehensive solution for heart failure management. The company was founded by Anthony I. Nunez and Harry D. Rowland in June 2007 and is headquartered in Lisle, IL. | Directeur/Membre du Conseil | - |
Biosensia Ltd.
 Biosensia Ltd. Packaged SoftwareTechnology Services Biosensia Ltd. develops multiplexing point of care in vitro diagnostics platform. It offers RapiPlex, a point-of-care diagnosis system based on a set of proprietary technologies capable of producing quantitative and qualitative laboratory quality test results. The company was founded by Gareth Redmond and Gabriel Crean in 2009 and is headquartered in Dublin, Ireland. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jennifer McMahon
| Sociétés | Poste | Fin |
|---|---|---|
Kernel Management Partners Ltd.
 Kernel Management Partners Ltd. Investment ManagersFinance Kernel Management Partners Ltd. (Kernel Capital) is a venture capital firm founded in 1999 by Niall Olden. The firm is headquartered in Cork, Ireland. | Analyste en capital-investissement | - |
Formation de Jennifer McMahon
| University College Dublin | Undergraduate Degree |
| UCD Michael Smurfit Graduate School of Business | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Kernel Management Partners Ltd.
Kernel Management Partners Ltd. Investment ManagersFinance Kernel Management Partners Ltd. (Kernel Capital) is a venture capital firm founded in 1999 by Niall Olden. The firm is headquartered in Cork, Ireland. | Finance |
Seroba BioVentures Ltd.
Seroba BioVentures Ltd. Investment ManagersFinance Seroba BioVentures Ltd (Seroba BioVentures) is a venture capital subsidiary of Kernel Management Partners Ltd founded in 2001 by Peter Sandys and Seamus O''Hara. The firm is headquartered in Dublin, Ireland. | Finance |
Endotronix, Inc.
Endotronix, Inc. Medical SpecialtiesHealth Technology Endotronix, Inc. develops wireless heart sensor technology. The firm has introduced the Cordella Heart Failure System, a comprehensive solution for heart failure management. The company was founded by Anthony I. Nunez and Harry D. Rowland in June 2007 and is headquartered in Lisle, IL. | Health Technology |
Biosensia Ltd.
Biosensia Ltd. Packaged SoftwareTechnology Services Biosensia Ltd. develops multiplexing point of care in vitro diagnostics platform. It offers RapiPlex, a point-of-care diagnosis system based on a set of proprietary technologies capable of producing quantitative and qualitative laboratory quality test results. The company was founded by Gareth Redmond and Gabriel Crean in 2009 and is headquartered in Dublin, Ireland. | Technology Services |
